You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Innovation-C101

Showing 1 - 25 of 9,352
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Shanghai (Ori-C101)

Recruiting
  • Hepatocellular Carcinoma
  • Ori-C101
  • Shanghai, China
    Zhongshan Hospital Fudan University
Dec 21, 2022

DFNB9 Trial (OTOV101N+OTOV101C Injections)

Not yet recruiting
  • DFNB9
  • OTOV101N+OTOV101C Injections
  • (no location specified)
Jun 2, 2023

Sex Work, Pre-Exposure Prophylaxis Trial in Chicago (C-PrEP+)

Recruiting
  • Sex Work
  • Pre-Exposure Prophylaxis
  • C-PrEP+
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 26, 2023

Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

Recruiting
  • Thyroid
  • +18 more
  • New Haven, Connecticut
  • +6 more
Apr 8, 2022

COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
  • Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
  • (no location specified)
Jun 19, 2023

Bradycardia Trial (CARDIX-101A, CARDIX-101B, CARDIX-101C)

Not yet recruiting
  • Bradycardia
  • CARDIX-101A, CARDIX-101B, CARDIX-101C
  • (no location specified)
Jul 18, 2022

Muscular Atrophy, Spinal Trial in Argentina, Brazil (OAV101)

Active, not recruiting
  • Muscular Atrophy, Spinal
  • OAV101
  • Caba, Buenos Aires, Argentina
  • +4 more
Oct 2, 2022

Diet-induced Elevations in LDL-C and Progression of

Recruiting
  • Hypercholesterolemia
    • Torrance, California
      Lundquist Institute for Biomedical Innovation at Harbor UCLA Med
    Feb 17, 2023

    Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

    Not yet recruiting
    • Low-grade Glioma
    • (no location specified)
    Oct 3, 2022

    Functional Disability Trial in Odense C (PONDUS®)

    Not yet recruiting
    • Functional Disability
    • PONDUS®
    • Odense C, Denmark
      University of Southern Denmark
    Sep 5, 2023

    Healthy Subjects, Submental Fat Trial in Seongnam (Polyene Phosphatidylcholine)

    Not yet recruiting
    • Healthy Subjects
    • Submental Fat
    • Polyene Phosphatidylcholine
    • Seongnam, Gyeonggi, Korea, Republic of
      Seoul National University Bundang Hospital
    Jul 25, 2022

    Anastomotic Leak Trial in Hamilton (Stream™ Platform, Stream™ Platform with Risk Score Omitted)

    Not yet recruiting
    • Anastomotic Leak
    • Stream™ Platform
    • Stream™ Platform with Risk Score Omitted
    • Hamilton, Ontario, Canada
    • +1 more
    Aug 8, 2023

    Spinal Cord Injury, Acute Trial in Worldwide (NG-101, Placebos)

    Active, not recruiting
    • Spinal Cord Injury, Acute
    • Praha, Czechia
    • +12 more
    Aug 24, 2022

    Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Decitabine and Cedazuridine
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    May 25, 2022

    Hepatocellular Carcinoma Trial in Pavia (TAC-101, Placebo)

    Terminated
    Has Results
    • Hepatocellular Carcinoma
    • Pavia, Italy
      I.R.C.C.S. San Matteo University Hospital, Golgi
    Jan 3, 2022

    Moderate or Severe Submental Fullness Trial in Seoul (Polyene Phosphatidylcholine, Placebo)

    Recruiting
    • Moderate or Severe Submental Fullness
    • Polyene Phosphatidylcholine
    • Placebo
    • Seoul, Korea, Republic of
      Chung Ang University Hospital
    Mar 15, 2022

    Amyotrophic Lateral Sclerosis, Frontotemporal Dementia Trial in Worldwide (TPN-101, 400 mg/day, Placebo)

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • Frontotemporal Dementia
    • TPN-101, 400 mg/day
    • Placebo
    • Orange, California
    • +4 more
    Mar 9, 2022

    Recurrent DLBCL, Recurrent Follicular Lymphoma, Refractory DLBCL Trial in Seattle (Laboratory Biomarker Analysis, Pembrolizumab,

    Active, not recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +3 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 20, 2022

    MIS-C and Other Complications Following SARS-CoV-2 Infection

    Recruiting
    • SARS CoV 2 Infection
    • +3 more
      • Copenhagen, Denmark
        Copenhagen University Hospital Rigshospitalet
      Jun 14, 2022

      Type2 Diabetes Trial in Aarhus C (Intervention, Placebo)

      Active, not recruiting
      • Type2 Diabetes
      • Intervention
      • Placebo
      • Aarhus C, Denmark
        Aarhus University
      May 17, 2022

      Solid Tumor Trial in United States (TR1801-ADC)

      Active, not recruiting
      • Unspecified Adult Solid Tumor, Protocol Specific
      • TR1801-ADC
      • Los Angeles, California
      • +4 more
      Oct 30, 2022

      Mental Health Issue, Mental Disorder Trial in Paris

      Not yet recruiting
      • Mental Health Issue
      • Mental Disorder
        • Paris, Île-de-France, France
        • +6 more
        May 23, 2023

        Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection, C. Diff Trial in Canada, United States (CP101)

        Completed
        Has Results
        • Clostridium Difficile Infection
        • +10 more
        • CP101
        • Scottsdale, Arizona
        • +56 more
        Aug 10, 2022

        Covid19 Trial in Ottawa (drug, dietary supplement, other)

        Suspended
        • Covid19
        • Vitamin D3 50,000 IU
        • +4 more
        • Ottawa, Ontario, Canada
          The Centre for Health Innovation
        Aug 8, 2022

        HCV, HIV Trial in Bangkok, Pathum wan (KP-Led HCV test and treat service)

        Recruiting
        • HCV, HIV
        • KP-Led HCV test and treat service
        • Bangkok, Bangkapi, Thailand
        • +2 more
        Jul 26, 2022